Condition: Bradycardia · Atrioventricular Block · Sinus Node Dysfunction · Sponsor: Boston Scientific Corporation
The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.
This description comes directly from the study's public registry record.
Jens Goetzke, Dipl.-Ing. (FH) · 800-227-3422 · septa_pmcf@bsci.com
Gena Kantor, MPH · 800-227-3422 · septa_pmcf@bsci.com
Always discuss trial participation with your own doctor first.
| St. Jan-Hospital | Bruges, Belgium | Recruiting |
| Clinique Saint-Pierre Ottignies-Hospital | Brussels, Belgium | Recruiting |
| CHRU de Lille | Lille, France | Recruiting |
| Hospital Europeen Georges-Pompidou (HEGP) | Paris, France | Recruiting |
| Marienhospital-Hospital | Osnabrück, Lower Saxony, Germany | Recruiting |
| Saarland University Hospital | Homburg, Saarland, Germany | Not Yet Recruiting |
| Azienda Ospedaliero-Universitaria di Ferrara-Hospital | Ferrara, Emilia-Romagna, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Ospedale Niguarda Ca Granda | Milan, Italy | Not Yet Recruiting |
| AOU Maggiore | Novara, Italy | Recruiting |
| Virgen de las Nieves University Hospital | Granada, Spain | Recruiting |
| Hospital Clinico Universitario Lozano Blesa | Zaragoza, Spain | Recruiting |
| Inselspital Bern | Bern, Switzerland | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07209852